{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:46:28Z","timestamp":1791103588790,"version":"4.1.0"},"reference-count":152,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.metabol.2014.01.011","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T09:32:12Z","timestamp":1391592732000},"page":"607-617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Obesity-associated mechanisms of hepatocarcinogenesis"],"prefix":"10.1016","volume":"63","author":[{"given":"Raffi","family":"Karagozian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Derd\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Baffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2014.01.011_bb0005","author":"World Health Organization"},{"issue":"5","key":"10.1016\/j.metabol.2014.01.011_bb0010","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.mcna.2011.06.005","article-title":"Impact of obesity on cardiovascular disease","volume":"95","author":"Zalesin","year":"2011","journal-title":"Med Clin North Am"},{"issue":"9793","key":"10.1016\/j.metabol.2014.01.011_bb0015","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(11)60814-3","article-title":"Health and economic burden of the projected obesity trends in the USA and the UK","volume":"378","author":"Wang","year":"2011","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.metabol.2014.01.011_bb0020","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0025","first-page":"13","article-title":"A prospective study of obesity and cancer risk (Sweden)","volume":"12","author":"Wolk","year":"2001","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0959-8049(94)90254-2","article-title":"Obesity and cancer risk: a Danish record-linkage study","volume":"30A","author":"Moller","year":"1994","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11912-010-0139-7","article-title":"Obesity and cancer risk: recent review and evidence","volume":"13","author":"Basen-Engquist","year":"2011","journal-title":"Curr Oncol Rep"},{"issue":"9612","key":"10.1016\/j.metabol.2014.01.011_bb0040","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.metabol.2014.01.011_bb0045","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1471-0528.2006.01021.x","article-title":"Obesity as a risk factor for development and poor prognosis of breast cancer","volume":"113","author":"Carmichael","year":"2006","journal-title":"BJOG"},{"issue":"9","key":"10.1016\/j.metabol.2014.01.011_bb0050","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/aje\/152.9.847","article-title":"Body mass index and colon cancer mortality in a large prospective study","volume":"152","author":"Murphy","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"5 Suppl. 1","key":"10.1016\/j.metabol.2014.01.011_bb0055","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary liver cancer: worldwide incidence and trends","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0060","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.metabol.2014.01.011_bb0065","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.metabol.2014.01.011_bb0070","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1210\/jc.2012-1267","article-title":"Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"97","author":"Zhang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.metabol.2014.01.011_bb0075","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","article-title":"Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005","volume":"27","author":"Altekruse","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/bjc.2012.492","article-title":"Metabolic syndrome and hepatocellular carcinoma risk","volume":"108","author":"Turati","year":"2013","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.metabol.2014.01.011_bb0085","first-page":"901","article-title":"Relation of body mass index to cancer risk in 362,552 Swedish men","volume":"17","author":"Samanic","year":"2006","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ijc.26338","article-title":"Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults","volume":"131","author":"Borena","year":"2012","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0095","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ijc.27645","article-title":"Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort","volume":"132","author":"Schlesinger","year":"2013","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.24397","article-title":"Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database","volume":"54","author":"Welzel","year":"2011","journal-title":"Hepatology"},{"issue":"16","key":"10.1016\/j.metabol.2014.01.011_bb0105","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0110","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.1840360609","article-title":"NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States","volume":"36","author":"Marrero","year":"2002","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.metabol.2014.01.011_bb0115","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.metabol.2014.01.011_bb0120","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1080\/00365520903171284","article-title":"Final results of a long-term, clinical follow-up in fatty liver patients","volume":"44","author":"Dam-Larsen","year":"2009","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0130","first-page":"97","article-title":"Liver morphology in morbid obesity: a literature study","volume":"8","author":"Andersen","year":"1984","journal-title":"Int J Obes"},{"issue":"4","key":"10.1016\/j.metabol.2014.01.011_bb0135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0168-8278(01)00151-9","article-title":"The spectrum of liver disease in the general population: lesson from the Dionysos study","volume":"35","author":"Bellentani","year":"2001","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0140","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.metabol.2014.01.011_bb0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/CS20080253","article-title":"Metabolic disturbances in non-alcoholic fatty liver disease","volume":"116","author":"Byrne","year":"2009","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.metabol.2014.01.011_bb0155","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.metabol.2014.01.011_bb0160","first-page":"291","article-title":"Steatosis and hepatocellular carcinoma risk","volume":"9","author":"Smedile","year":"2005","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.metabol.2014.01.011_bb0165","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cld.2009.07.007","article-title":"NASH and HCC","volume":"13","author":"Page","year":"2009","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.metabol.2014.01.011_bb0170","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in nonalcoholic fatty liver disease: an emerging menace","volume":"56","author":"Baffy","year":"2012","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1872-034X.2011.00872.x","article-title":"Hepatocellular carcinoma in non-alcoholic steatohepatitis: growing evidence of an epidemic?","volume":"42","author":"Hashimoto","year":"2012","journal-title":"Hepatol Res"},{"issue":"4","key":"10.1016\/j.metabol.2014.01.011_bb0180","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/hep.21103","article-title":"Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C","volume":"43","author":"Sanyal","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0185","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0190","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-1746.2008.05640.x","article-title":"Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C","volume":"24","author":"Yatsuji","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.metabol.2014.01.011_bb0195","doi-asserted-by":"crossref","first-page":"1342 e2","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"White","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0200","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1872-034X.2011.00915.x","article-title":"Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients","volume":"42","author":"Arase","year":"2012","journal-title":"Hepatol Res"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0205","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ajg.2011.327","article-title":"Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma","volume":"107","author":"Kawamura","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ajcp\/105.1.65","article-title":"Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients","volume":"105","author":"Nzeako","year":"1996","journal-title":"Am J Clin Pathol"},{"issue":"15","key":"10.1016\/j.metabol.2014.01.011_bb0215","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/sj.onc.1210279","article-title":"TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer","volume":"26","author":"Hussain","year":"2007","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0220","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1478-3231.2003.00869.x","article-title":"Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis","volume":"23","author":"Kew","year":"2003","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.metabol.2014.01.011_bb0225","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jama.1979.03300070040020","article-title":"Epidemiology of hepatocellular adenoma. The role of oral contraceptive use","volume":"242","author":"Rooks","year":"1979","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.metabol.2014.01.011_bb0230","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1477-2574.2010.00222.x","article-title":"Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases","volume":"12","author":"Stoot","year":"2010","journal-title":"HPB (Oxford)"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MAJ.0b013e3181c4af27","article-title":"Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis","volume":"339","author":"Madhoun","year":"2010","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0240","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/modpathol.2009.174","article-title":"Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers","volume":"23","author":"Yeh","year":"2010","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.metabol.2014.01.011_bb0245","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.5858\/132.11.1761","article-title":"Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?","volume":"132","author":"Guzman","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0250","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.22734","article-title":"Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis","volume":"49","author":"Paradis","year":"2009","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.metabol.2014.01.011_bb0255","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1590\/S0100-879X2009005000019","article-title":"Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?","volume":"42","author":"Chagas","year":"2009","journal-title":"Braz J Med Biol Res"},{"issue":"10","key":"10.1016\/j.metabol.2014.01.011_bb0260","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/ijc.25797","article-title":"Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis","volume":"128","author":"Ertle","year":"2010","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.metabol.2014.01.011_bb0265","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1185\/03007995.2010.506375","article-title":"Population-based risk factors and resource utilization for HCC: US perspective","volume":"26","author":"Sanyal","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"4 (Suppl.)","key":"10.1016\/j.metabol.2014.01.011_bb0270","first-page":"241A","article-title":"Nonalcoholic fatty liver disease without cirrhosis is an emergent and independent risk factor of hepatocellular carcinoma: a population based study","volume":"56","author":"Rahman","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0275","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/jhep.2002.33713","article-title":"Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?","volume":"36","author":"Nair","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.metabol.2014.01.011_bb0280","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2002.36780","article-title":"Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus","volume":"36","author":"Hassan","year":"2002","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.metabol.2014.01.011_bb0285","doi-asserted-by":"crossref","first-page":"951 e1","DOI":"10.1016\/j.amjmed.2010.05.013","article-title":"Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients","volume":"123","author":"Kawamura","year":"2010","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0290","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2008.03.073","article-title":"Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B\/C infection: a follow-up study in Taiwan","volume":"135","author":"Chen","year":"2008","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.metabol.2014.01.011_bb0295","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cgh.2006.05.013","article-title":"Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis","volume":"4","author":"N'Kontchou","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.metabol.2014.01.011_bb0300","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ng0802-339","article-title":"Molecular pathogenesis of human hepatocellular carcinoma","volume":"31","author":"Thorgeirsson","year":"2002","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.metabol.2014.01.011_bb0305","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"Farazi","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.metabol.2014.01.011_bb0310","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0002-9440(10)63495-5","article-title":"Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis","volume":"163","author":"Lee","year":"2003","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.metabol.2014.01.011_bb0315","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/jhep.2000.19797","volume":"32","author":"Kondo","year":"2000","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0320","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00204-012-0931-2","article-title":"Cellular and molecular mechanisms of hepatocellular carcinoma: an update","volume":"87","author":"Aravalli","year":"2013","journal-title":"Arch Toxicol"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0325","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.25670","article-title":"Fibrosis-dependent mechanisms of hepatocarcinogenesis","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2014.01.011_bb0330","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/B978-0-12-385233-5.00009-X","article-title":"Signaling networks in human hepatocarcinogenesis\u2014novel aspects and therapeutic options","volume":"97","author":"Breuhahn","year":"2010","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0335","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc1300","article-title":"Cancer as a robust system: implications for anticancer therapy","volume":"4","author":"Kitano","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0340","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-0032-1306424","article-title":"Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil","volume":"32","author":"Torres","year":"2012","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0345","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/hep.22724","article-title":"Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD\u2013clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network","volume":"49","author":"Brunt","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0350","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/hep.23070","article-title":"What's in a NAme?","volume":"50","author":"Brunt","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0355","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-0031-1276643","article-title":"Genetics of alcoholic and nonalcoholic fatty liver disease","volume":"31","author":"Anstee","year":"2011","journal-title":"Semin Liver Dis"},{"issue":"7","key":"10.1016\/j.metabol.2014.01.011_bb0360","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"issue":"9492","key":"10.1016\/j.metabol.2014.01.011_bb0365","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(05)67483-1","article-title":"Obesity","volume":"366","author":"Haslam","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0370","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","article-title":"Adipose tissue expandability, lipotoxicity and the metabolic syndrome\u2014an allostatic perspective","volume":"1801","author":"Virtue","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0375","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1172\/JCI45887","article-title":"Adipose tissue remodeling and obesity","volume":"121","author":"Sun","year":"2011","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0380","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, inflammation, and insulin resistance","volume":"132","author":"Shoelson","year":"2007","journal-title":"Gastroenterology"},{"issue":"7121","key":"10.1016\/j.metabol.2014.01.011_bb0385","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.metabol.2014.01.011_bb0390","doi-asserted-by":"crossref","first-page":"E877","DOI":"10.1152\/ajpendo.00626.2010","article-title":"Regulation of HIF-1{alpha} activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia","volume":"300","author":"He","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0395","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep.23046","article-title":"Adipokines in liver diseases","volume":"50","author":"Marra","year":"2009","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.metabol.2014.01.011_bb0400","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/gut.2009.199661","article-title":"Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications","volume":"59","author":"Stickel","year":"2010","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0405","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression","volume":"140","author":"Park","year":"2010","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.metabol.2014.01.011_bb0410","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.lfs.2005.04.004","article-title":"Leptin enhances TNF-alpha production via p38 and JNK MAPK in LPS-stimulated Kupffer cells","volume":"77","author":"Shen","year":"2005","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0415","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/hep.20965","article-title":"Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells","volume":"42","author":"Aleffi","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0420","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jhep.2004.08.020","article-title":"Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease","volume":"41","author":"Angulo","year":"2004","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0425","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1158\/0008-5472.CAN-06-3075","article-title":"Concomitant activation of the JAK\/STAT, PI3K\/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells","volume":"67","author":"Saxena","year":"2007","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.metabol.2014.01.011_bb0430","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/er.2011-1015","article-title":"The role of adiponectin in cancer: a review of current evidence","volume":"33","author":"Dalamaga","year":"2012","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0435","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tips.2004.12.011","article-title":"AMPK, the metabolic syndrome and cancer","volume":"26","author":"Luo","year":"2005","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"10.1016\/j.metabol.2014.01.011_bb0440","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki","year":"2006","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0445","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.metabol.2014.01.011_bb0450","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"issue":"2 Pt. 1","key":"10.1016\/j.metabol.2014.01.011_bb0455","first-page":"E321","article-title":"Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification","volume":"274","author":"Diraison","year":"1998","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0460","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1097-2765(05)00010-9","article-title":"Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob\/ob mice","volume":"6","author":"Shimomura","year":"2000","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0465","first-page":"72","article-title":"SREBP-1c transcription factor and lipid homeostasis: clinical perspective","volume":"68","author":"Ferre","year":"2007","journal-title":"Horm Res"},{"issue":"7394","key":"10.1016\/j.metabol.2014.01.011_bb0470","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature10986","article-title":"A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism","volume":"484","author":"Herman","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2014.01.011_bb0475","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/ncomms2537","article-title":"De novo lipogenesis in human fat and liver is linked to ChREBP-beta and metabolic health","volume":"4","author":"Eissing","year":"2013","journal-title":"Nat Commun"},{"issue":"16","key":"10.1016\/j.metabol.2014.01.011_bb0480","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1073\/pnas.161284298","article-title":"A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver","volume":"98","author":"Yamashita","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.metabol.2014.01.011_bb0485","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1073\/pnas.0730817100","article-title":"Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver","volume":"100","author":"Kabashima","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0490","first-page":"102","article-title":"Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation","volume":"4","author":"Lee","year":"2012","journal-title":"Am J Transl Res"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0495","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbalip.2009.10.006","article-title":"Lipid homeostasis, lipotoxicity and the metabolic syndrome","volume":"1801","author":"Unger","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0500","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/sj.cdd.4401840","article-title":"From acute ER stress to physiological roles of the unfolded protein response","volume":"13","author":"Wu","year":"2006","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0505","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1053\/j.gastro.2007.10.039","article-title":"Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease","volume":"134","author":"Puri","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0510","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2217\/clp.09.85","article-title":"Mechanisms and clinical implications of hepatocyte lipoapoptosis","volume":"5","author":"Cazanave","year":"2010","journal-title":"Clin Lipidol"},{"issue":"5695","key":"10.1016\/j.metabol.2014.01.011_bb0515","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1103160","article-title":"Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes","volume":"306","author":"Ozcan","year":"2004","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0520","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jhep.2009.01.027","article-title":"Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN","volume":"50","author":"Vinciguerra","year":"2009","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0525","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/hep.21752","article-title":"Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes","volume":"46","author":"Joshi-Barve","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.metabol.2014.01.011_bb0530","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrc1046","article-title":"Radical causes of cancer","volume":"3","author":"Hussain","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tem.2010.09.002","article-title":"Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter","volume":"22","author":"Lodhi","year":"2011","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0540","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MOL.0b013e3282ff5e55","article-title":"Hepatic triglyceride synthesis and nonalcoholic fatty liver disease","volume":"19","author":"Choi","year":"2008","journal-title":"Curr Opin Lipidol"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0545","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tem.2011.02.003","article-title":"Regulation of lipid droplets by autophagy","volume":"22","author":"Dong","year":"2011","journal-title":"Trends Endocrinol Metab"},{"issue":"7242","key":"10.1016\/j.metabol.2014.01.011_bb0550","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism","volume":"458","author":"Singh","year":"2009","journal-title":"Nature"},{"issue":"6865","key":"10.1016\/j.metabol.2014.01.011_bb0555","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.metabol.2014.01.011_bb0560","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0565","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.metabol.2014.01.011_bb0570","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nrc3174","article-title":"Molecular mechanisms of cancer development in obesity","volume":"11","author":"Khandekar","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0575","first-page":"348","article-title":"Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma","volume":"58","author":"Kim","year":"1998","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0580","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/hep.510260310","article-title":"Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes","volume":"26","author":"Tanaka","year":"1997","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.metabol.2014.01.011_bb0585","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrm3313","article-title":"MicroRNAs in metabolism and metabolic disorders","volume":"13","author":"Rottiers","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2014.01.011_bb0590","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-nutr-081810-160756","article-title":"The role of microRNAs in cholesterol efflux and hepatic lipid metabolism","volume":"31","author":"Moore","year":"2011","journal-title":"Annu Rev Nutr"},{"issue":"7043","key":"10.1016\/j.metabol.2014.01.011_bb0595","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0600","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/hep.23010","article-title":"MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia","volume":"50","author":"Mott","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0605","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.bjc.6606010","article-title":"The role of microRNAs in liver cancer progression","volume":"104","author":"Huang","year":"2011","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.metabol.2014.01.011_bb0610","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1478-3231.2012.02795.x","article-title":"MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma","volume":"32","author":"Augello","year":"2012","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0615","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00535-012-0661-5","article-title":"Role of miR-122 and lipid metabolism in HCV infection","volume":"48","author":"Fukuhara","year":"2013","journal-title":"J Gastroenterol"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0620","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.metabol.2014.01.011_bb0625","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2012.11.042","article-title":"Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease","volume":"58","author":"Derdak","year":"2013","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.metabol.2014.01.011_bb0630","doi-asserted-by":"crossref","first-page":"e23937","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"Cermelli","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.metabol.2014.01.011_bb0635","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccr.2007.10.028","article-title":"p53 enters the microRNA world","volume":"12","author":"Hermeking","year":"2007","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0640","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ygeno.2013.04.001","article-title":"Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections","volume":"102","author":"Tornesello","year":"2013","journal-title":"Genomics"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0645","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cell.2012.04.026","article-title":"Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence","volume":"149","author":"Li","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0650","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cell.2006.05.036","article-title":"TIGAR, a p53-inducible regulator of glycolysis and apoptosis","volume":"126","author":"Bensaad","year":"2006","journal-title":"Cell"},{"issue":"5780","key":"10.1016\/j.metabol.2014.01.011_bb0655","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1126863","article-title":"p53 regulates mitochondrial respiration","volume":"312","author":"Matoba","year":"2006","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0660","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2010.08.007","article-title":"Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease","volume":"54","author":"Derdak","year":"2011","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0665","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1097-2765(01)00323-9","article-title":"Regulation of PTEN transcription by p53","volume":"8","author":"Stambolic","year":"2001","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0670","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0675","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.metabol.2014.01.011_bb0680","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of activated stellate cells limits liver fibrosis","volume":"134","author":"Krizhanovsky","year":"2008","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.metabol.2014.01.011_bb0685","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/cas.12118","article-title":"Roles and mechanisms of cellular senescence in regulation of tissue homeostasis","volume":"104","author":"Ohtani","year":"2013","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.metabol.2014.01.011_bb0690","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1172\/JCI64098","article-title":"Cellular senescence and the senescent secretory phenotype: therapeutic opportunities","volume":"123","author":"Tchkonia","year":"2013","journal-title":"J Clin Invest"},{"issue":"7456","key":"10.1016\/j.metabol.2014.01.011_bb0695","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.metabol.2014.01.011_bb0700","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1148\/radiol.2221010767","article-title":"Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 U.S. residents","volume":"222","author":"Brancatelli","year":"2002","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0705","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0676.1997.tb01031.x","article-title":"Hepatic stellate cell activation in dysplastic nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesis","volume":"17","author":"Park","year":"1997","journal-title":"Liver"},{"issue":"4","key":"10.1016\/j.metabol.2014.01.011_bb0710","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.gtc.2007.08.010","article-title":"Hepatic precancerous lesions and small hepatocellular carcinoma","volume":"36","author":"Hytiroglou","year":"2007","journal-title":"Gastroenterol Clin North Am"},{"issue":"9615","key":"10.1016\/j.metabol.2014.01.011_bb0715","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.metabol.2014.01.011_bb0720","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrmicro3089","article-title":"The gut microbiota and obesity: from correlation to causality","volume":"11","author":"Zhao","year":"2013","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.metabol.2014.01.011_bb0725","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/hep.21308","article-title":"Pattern recognition receptors: a contemporary view on liver diseases","volume":"44","author":"Szabo","year":"2006","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.metabol.2014.01.011_bb0730","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cell.2005.04.014","article-title":"IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis","volume":"121","author":"Maeda","year":"2005","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.metabol.2014.01.011_bb0735","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.metabol.2014.01.011_bb0740","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.1840120505","article-title":"Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors","volume":"12","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.metabol.2014.01.011_bb0745","first-page":"1349","article-title":"Liver pathology in morbidly obese patients with and without diabetes","volume":"85","author":"Silverman","year":"1990","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0750","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.metabol.2014.01.011_bb0755","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994","volume":"341","author":"Alter","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.metabol.2014.01.011_bb0760","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/hep.510280632","article-title":"Prognosis of chronic hepatitis C: results of a large, prospective cohort study","volume":"28","author":"Niederau","year":"1998","journal-title":"Hepatology"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514000365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514000365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:02:32Z","timestamp":1758427352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049514000365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":152,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0026049514000365"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2014.01.011","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity-associated mechanisms of hepatocarcinogenesis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2014.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}